Author

Contributions

  • A.B. Reitz (Editor) - Contributor
  • S.L. Dax (Editor) - Contributor

Publication

2000 - Elsevier Science

Language

English

Word Count

53,000 words, Guess

Page Count

212 pages

Physical Format

Hardcover

Identifiers

  • Open LibraryOL9521524M
  • ISBN-139780762305933
  • ISBN-100762305932
  • OCLC Control Number166344406
  • Goodreads4415372

Description

Volume 5 of Advances in Medicinal Chemistry contains four intriguing and detailed accounts of the close interface between synthetic chemistry, structure-activity relationships, biochemistry, and pharmacology. In Chapter 1, there is a comprehensive survey of the immunophilin area specifically focussing on neuroregenerative applications in the central nervous system. In Chapter 2, there is an overview of the development of a potent analgesic compound that works via modulation of neuronal nicotinic acetylcholine receptors. In Chapter 3, there is a description of dopamine D-2 autoreceptor partial agonists as potential therapy for the treatment of schizophrenia. In Chapter 4, there is a summary of the successful program in which potent non-peptide inhibitors of HIV protease from the AIDS virus were developed.

First Sentence

In the course of pharmaceutical research, a large number of enzyme families have been extensively studied and utilized as targets for therapeutic drug design.

Subjects

Other Editions

  • Advances in Medicinal Chemistry, Volume 5 (Advances in Medicinal Chemistry)HardcoverElsevier Science2000-01-01

Reader Reviews

No reviews yet for this book.

Be the first to share your thoughts!